Circulatory [phsf]
Response [orga]
Melatonin [horm, nsba, orch, phsu]
postmenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
Young [tmco]
Men [popg]
Women [popg]
Melatonin [horm, nsba, orch, phsu]
vascular reactivity [clna]
Blood Pressure [orgf]
Norepinephrine [nsba, orch, phsu]
Levels [qlco]
investigated [ftcn]
effects [qlco]
postmenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
Oral [spco]
Melatonin [horm, nsba, orch, phsu]
mg% [qnco]
placebo [topp]
DOUBLE BLIND [resa]
Administered [ftcn]
untreated [fndg]
postmenopausal [tmco]
Women [popg]
treated [topp]
Transdermal [ftcn]
Estradiol [horm, phsu, strd]
MU/day [qnco]
Plus [qlco]
Cyclic [tmco]
medroxyprogesterone acetate [horm, phsu, strd]
5 Days [tmco]
mg day [qnco]
days [tmco]
Carotid Artery, Internal [bpoc]
Pulsatility index [clna]
Index [inpr]
Downstream [spco]
Resistance [menp]
Blood flow [orgf]
Blood Pressure [orgf]
catecholamine levels [lbtr]
Evaluated [ftcn]
untreated [fndg]
postmenopausal [tmco]
Women [popg]
Melatonin [horm, nsba, orch, phsu]
ineffective [idcn]
Hormone replacement therapy [topp]
treated [topp]
Women [popg]
Study [mnob]
Estrogenic [horm, orch, phsu]
Phase [tmco]
Melatonin [horm, nsba, orch, phsu]
Reduced [qlco]
>90 [qnco]
Systolic [tmco]
mmHg [qnco]
P NOS [aapp, imft]
Diastolic [clna]
mmHg [qnco]
P NOS [aapp, imft]
mmHg [qnco]
P NOS [aapp, imft]
Blood Pressure [orgf]
Norepinephrine [nsba, orch, phsu]
pg/mL [qnco]
P NOS [aapp, imft]
Epinephrine level [lbpr]
Reduced [qlco]
Resistance [menp]
Blood [tisu]
Row [idcn]
Carotid Artery, Internal [bpoc]
Evaluated [ftcn]
Pulsatility index [clna]
Decreased [qnco]
P NOS [aapp, imft]
Pre-existing [qlco]
Pulsatility index [clna]
Values [qlco]
R- [spco]
P NOS [aapp, imft]
Circulatory [phsf]
Response [orga]
Melatonin [horm, nsba, orch, phsu]
postmenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
untreated [fndg]
postmenopausal [tmco]
Women [popg]
Physiological [ftcn]
Pharmacological [bmod]
CARDIOVASCULAR [bdsy]
postmenopausal [tmco]
Women [popg]
